TPH1 catalyzed the reaction of enhanced degradation of tryptophan to serotonin, and its oncogenetic has been discovered in breast cancer, bladder cell carcinoma, and colon cancer [31–33]. The gene discussed is TPH1; the disease is malignant colon neoplasm.